FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

16554211000001108: Memantine 20mg tablets (PI) (Mawdsley-Brooks & Company Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Feb 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
293761000001119 Memantine 20mg tablets (PI) (Mawdsley-Brooks & Company Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
57890901000001112 Memantine 20mg tablets (Mawdsley-Brooks & Company Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Memantine 20mg tablets (PI) (Mawdsley-Brooks & Company Ltd) (product) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Memantine 20mg tablets (PI) (Mawdsley-Brooks & Company Ltd) (product) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Memantine 20mg tablets (PI) (Mawdsley-Brooks & Company Ltd) (product) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Memantine 20mg tablets (PI) (Mawdsley-Brooks & Company Ltd) (product) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Memantine 20mg tablets (PI) (Mawdsley-Brooks & Company Ltd) (product) Is a Memantine 20mg tablets true Inferred relationship Existential restriction modifier
Memantine 20mg tablets (PI) (Mawdsley-Brooks & Company Ltd) (product) Has active ingredient Memantine true Inferred relationship Existential restriction modifier
Memantine 20mg tablets (PI) (Mawdsley-Brooks & Company Ltd) (product) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Memantine 20mg tablets (PI) (Mawdsley-Brooks & Company Ltd) (product) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Memantine 20mg tablets (PI) (Mawdsley-Brooks & Company Ltd) (product) Has specific active ingredient Memantine hydrochloride true Inferred relationship Existential restriction modifier
Memantine 20mg tablets (PI) (Mawdsley-Brooks & Company Ltd) (product) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Memantine 20mg tablets (PI) (Mawdsley-Brooks & Company Ltd) (product) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Memantine 20mg tablets (PI) (Mawdsley-Brooks & Company Ltd) (product) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Memantine 20mg tablets (PI) (Mawdsley-Brooks & Company Ltd) (product) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Memantine 20mg tablets (PI) (Mawdsley-Brooks & Company Ltd) 28 tablet (product) Has AMP True Memantine 20mg tablets (PI) (Mawdsley-Brooks & Company Ltd) (product) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start